newsDanish, Norwegian and Icelandic authorities suspend use of COVID-19 Vaccine AstraZeneca12 March 2021 | By Hannah Balfour (European Pharmaceutical Review)Several countries have temporarily stopped the use of the vaccine while reports of blood clots are investigated by the EMA’s pharmacovigilance committee and other authorities.
newsIndia’s Covaxin® 81 percent effective against COVID-198 March 2021 | By Hannah Balfour (European Pharmaceutical Review)An interim analysis reveals the Covaxin® (BBV152) vaccine was relatively safe and 81 percent effective in preventing symptomatic COVID-19.
newsEMA issues its requirements for adapting COVID-19 vaccines for viral variants26 February 2021 | By Hannah Balfour (European Pharmaceutical Review)The European Medicines Agency has set out its guidelines for vaccine manufacturers adapting their approved COVID-19 vaccines to combat viral variants.
newsAstraZeneca’s COVID-19 vaccines listed for emergency use by WHO17 February 2021 | By Hannah Balfour (European Pharmaceutical Review)The Emergency Use Listing will allow doses of the COVID-19 vaccines to be distributed through COVAX, the WHO’s vaccine allocation facility.
newsAfrica to receive first COVID-19 vaccine doses in February8 February 2021 | By Hannah Balfour (European Pharmaceutical Review)COVAX has allocated 90 million doses of AstraZeneca’s COVID-19 vaccine and 320,000 doses of the Pfizer-BioNTech vaccine to African countries.
newsAstraZeneca’s COVID-19 vaccine prevents severe disease and hospitalisation in Phase III trials3 February 2021 | By Hannah Balfour (European Pharmaceutical Review)A preliminary analysis suggests the COVID-19 Vaccine AstraZeneca was 74 percent effective after the first dose and 82 percent effective with a 12-week inter-dose interval.
newsEMA committee recommends 13 medicines for approval in January meeting1 February 2021 | By Hannah Balfour (European Pharmaceutical Review)The committee for human medicinal products recommended AstraZeneca’s COVID-19 vaccine be granted conditional marketing authorisation alongside 12 other approvals.
newsEMA begins rolling review of AstraZeneca COVID-19 vaccine2 October 2020 | By Victoria Rees (European Pharmaceutical Review)The EMA's human medicines committee has initiated a rolling review of AstraZeneca's COVID-19 vaccine candidate to test its efficacy.
![syringe drawing from a vial labelled AstraZeneca COVID-19 Vaccine [Credit: Juan Roballo / Shutterstock.com].](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/shutterstock_1863086803-300x278.jpg)
![syringe drawing from a vial labelled AstraZeneca COVID-19 Vaccine [Credit: Juan Roballo / Shutterstock.com].](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/shutterstock_1863086803.jpg)
